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Abstract
Cockayne syndrome (CS) is a devastating progeria most often caused by mutations in the CSB gene encoding a SWI/SNF
family chromatin remodeling protein. Although all CSB mutations that cause CS are recessive, the complete absence of CSB
protein does not cause CS. In addition, most CSB mutations are located beyond exon 5 and are thought to generate only C-
terminally truncated protein fragments. We now show that a domesticated PiggyBac-like transposon PGBD3, residing within
intron 5 of the CSB gene, functions as an alternative 39 terminal exon. The alternatively spliced mRNA encodes a novel
chimeric protein in which CSB exons 1–5 are joined in frame to the PiggyBac transposase. The resulting CSB-transposase
fusion protein is as abundant as CSB protein itself in a variety of human cell lines, and continues to be expressed by primary
CS cells in which functional CSB is lost due to mutations beyond exon 5. The CSB-transposase fusion protein has been highly
conserved for at least 43 Myr since the divergence of humans and marmoset, and appears to be subject to selective
pressure. The human genome contains over 600 nonautonomous PGBD3-related MER85 elements that were dispersed
when the PGBD3 transposase was last active at least 37 Mya. Many of these MER85 elements are associated with genes
which are involved in neuronal development, and are known to be regulated by CSB. We speculate that the CSB-
transposase fusion protein has been conserved for host antitransposon defense, or to modulate gene regulation by MER85
elements, but may cause CS in the absence of functional CSB protein.
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Introduction
The human genome is replete with interlopers — transposable
DNA elements, retrotransposable RNA elements such as SINEs
and LINEs, and a dizzying variety of lesser-known elements —
which together account for as much as half of our DNA [1].
Although much of this ‘‘junk’’ DNA is selfish and surprisingly
harmless, the constant turnover of these elements is an important
source of insertional mutagenesis with benign [2] and malign [3]
consequences. Indeed, eukaryotes often recruit mobile elements to
perform critical functions — a process known as domestication or
exaptation [4]. For example, the RAG1 recombinase, which
diversifies the adaptive immune response in mammals, was
domesticated aeons ago from a Transib-family transposase [5].
A similarly domesticated DNA transposon is responsible for the
programmed genomic rearrangements found in many ciliates [6],
and a pogo-like transposase gave rise to the centromeric CEN-P
protein family [7] which mediates host genome surveillance for
retrotransposons in Schizosaccharomyces pombe [8]. More recently in
the primate lineage, a mariner-like transposase was fused to a SET
histone methyltransferase domain by de novo exonization; the fusion
protein retains the ancestral DNA binding activity of the
transposase, and may function as a transcriptional regulator at
dispersed mariner-like repeat elements [9]. Here we report
identification of an evolutionarily conserved PiggyBac transposase
fusion protein that may play a critical, and previously unsuspected,
role in a well-studied human disease, Cockayne syndrome (CS).
PiggyBac elements, first characterized in the cabbage looper
moth Trichoplusia ni [10,11], have now been identified in a variety
of eukaryotes from protozoa [12] to primates [1]. A typical
PiggyBac element contains a 1.8 kb ORF encoding a 68 kDa
transposase; the boundaries of the element are defined by 13–
15 nt terminal inverted repeats, which are in turn flanked by a
duplication of the target site TTAA [13]. The T. ni PiggyBac
transposon is a useful tool for germline manipulation because it is
active in a wide range of species including mammals [14] and has
been considered as a possible gene therapy vector [15]. The five
PiggyBac elements in the human genome (PGBD1-5) are variously
conserved among vertebrates; PGBD5 dates to before the teleost/
tetrapod split, whereas PGBD3 and PGBD4 are restricted to
primates [1,13].
CS is a devastating inherited progeria characterized by severe
post-natal growth failure and progressive neurological dysfunction
[16]. Most cases of CS reflect mutations in the Cockayne
syndrome Group B (CSB, also known as ERCC6) gene, a SWI/
SNF-like DNA-dependent ATPase [17–19] that can wind DNA
[20] and remodel chromatin in vitro [21]; the remaining cases of
CS are caused by mutations in the CSA gene, and by rare alleles of
the xeroderma pigmentosum genes XPB, XPD, and XPG [22]. All
of these factors were originally identified as being involved in the
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[23,24]. While searching for an activity that could better explain
the CS phenotype, we found that CSB has a general chromatin
remodeling function [25] which could account for the pleiotropic
effects of CSB mutations and the characteristic wasting of CS [26].
Alternatively, CS may be caused by defects in transcription
initiation [27,28], or by a partial failure to repair oxidative DNA
damage. CSB is known to enhance repair of 8-hydroxyguanine
lesions [29], and mice doubly mutant for CSB and the 8-
hydroxyguanine glycosylase OGG1 are severely deficient in global
repair of endogenous oxidative DNA damage [30]. Similarly,
complete inactivation of nucleotide excision repair (NER) in mice
doubly mutant for CSB and XPA mimics CS and suppresses the
somatotroph axis [31,32]. As yet unexplained, however, is why
complete absence of CSB does not cause CS, although all CS
mutations are recessive [33–35].
Here we show that the PiggyBac transposable element PGBD3
embedded within intron 5 of the CSB gene functions as an
alternative 39 terminal exon (‘‘exon trap’’); as a result, alternative
splicing of the CSB primary transcript generates two mRNAs, one
encoding all 21 exons of the CSB protein, and the other an equally
abundant CSB-related protein in which the first 5 exons of CSB
are fused to the PGBD3 transposase. Sequence comparisons of
PGBD3 with PiggyBac pseudogenes in humans and other primates
suggest that PGBD3 was domesticated soon after it transposed into
the CSB gene. Indeed, conservation of the alternatively spliced
PGBD3 element in the CSB genes of chimpanzee, orangutan,
Rhesus macaque and marmoset over at least 43 Myr of evolution
[36], together with a preponderance of synonymous mutations,
strongly suggest that the fusion protein has been selected for an
advantageous function in its primate host. We speculate that the
CSB-transposase fusion protein originally played a role in host
genome defense by repressing transposition of autonomous
PGBD3 elements and the hundreds of nonautonomous PGBD3-
dependent MER85 elements derived from them. We also find an
association of MER85 elements with a subset of CSB-regulated
genes and genes involved in neuronal development, suggesting
that the fusion protein may later have acquired the ability to
modulate gene regulatory networks. Finally, we show that the
CSB-transposase fusion protein continues to be expressed in CS
primary cells lacking functional CSB protein, implying that the
fusion protein could contribute to the CS phenotype, or even
transform the mild UV sensitivity caused by complete loss of CSB-
related proteins [33] into a true progeria.
Results
CSB-PGBD3 Fusion Transcript Is a Major Product of the
CSB Gene
Intron 5 of the human CSB gene is host to a PiggyBac
transposable element known as PGBD3 (Figure 1A). We initially
noted that the RefSeq transcript for PGBD3 (along with four of
seven deposited mRNAs) consists of the 39 region of CSB exon 5
spliced to the entire PiggyBac coding region. The PGBD3
transposase ORF is flanked by a 39 splice acceptor site just 7 nt
upstream of the first methionine, and a polyadenylation site about
130 nt downstream of the termination codon. Moreover, the CSB
and PGBD3 coding regions are in frame across this splice junction,
suggesting that transcripts initiating at a normal CSB promoter
could be alternatively spliced to the PiggyBac element instead of
exon 6, thus generating a CSB-PGBD3 fusion protein (Figure 1B).
In this fusion protein, the N-terminal 465 residues of CSB
(including the acidic domain but not the ATPase) would be
tethered to the entire PiggyBac transposase. In fact, two of the
seven PGBD3 GenBank mRNA sequences (BC034479 and
AK291018) appear to be just such variants, starting at either the
noncoding CSB exon 1 (AK291018) or an alternative noncoding
exon 1 (BC034479) and ending just beyond the PGBD3
polyadenylation site. Four other PGBD3 GenBank mRNA
sequences consist of the 39 region of CSB exon 5 spliced to the
entire PiggyBac coding region, suggesting the existence of an
unusual cryptic promoter within exon 5 (the sixth mRNA, likely
incomplete, begins within the transposase ORF). We sought to
confirm the existence of such alternatively spliced transcripts, and
to determine whether the transcripts initiate at the putative cryptic
promoter within exon 5 or at a normal CSB transcription start site.
We were able to detect the predicted CSB-PGBD3 fusion
transcripts by quantitative, real-time RT-PCR (Q-RT-PCR) using
HeLa mRNA as template, forward primers for the 39 half of CSB
exon 5 which is shared by the CSB and predicted fusion mRNAs,
and reverse primers which are specific for either CSB exon 6 or
the PGBD3 element (Figure 2A). The fusion products exhibited
the expected size (Figure 2B) and sequence (data not shown), and
were approximately 2-fold more abundant than the equivalent
CSB products (Figure S1). Moreover, we readily detected fusion
products using forward primers for CSB exons 2, 3 and 4,
indicating that a significant fraction of the CSB-PGBD3 fusion
transcripts initiate far upstream of the putative cryptic promoter,
presumably at a natural CSB initiation site. These full-length CSB-
PGBD3 fusion transcripts do not reflect template strand switching
by reverse transcriptase or recombination during PCR [37] within
exon 5, because alternatively spliced fusion transcripts lacking
exon 5 were also observed (Figure 2), and the abundance of the
fusion products was not diminished in control experiments where
either one of the potentially recombining mRNAs was sequestered
within a cDNA:mRNA hybrid by a preliminary reverse
transcription step using an mRNA-specific primer (data not
shown).
Using a subset of these primer combinations, we also detected
CSB-PGBD3 fusion transcripts in three other cell lines: hTERT-
Author Summary
For reasons that are still unclear, genetic defects in DNA
repair can cause diseases that resemble aspects of
premature ageing (‘‘segmental progerias’’). Cockayne
syndrome (CS) is a particularly devastating progeria most
commonly caused by mutations in the CSB chromatin
remodeling gene. About 43 million years ago, before
humans diverged from marmosets, one of the last
PiggyBac transposable elements to invade the human
lineage landed within intron 5 of the 21 exon CSB gene. As
a result, the CSB locus now encodes two equally abundant
proteins generated by alternative mRNA splicing: the
original full length CSB protein, and a novel CSB-PiggyBac
fusion protein in which the N-terminus of CSB is fused to
the complete PiggyBac transposase. Conservation of the
CSB-PiggyBac fusion protein since marmoset suggests that
it is normally beneficial, demonstrating once again that
‘‘selfish’’ transposable elements can be exploited or
‘‘domesticated’’ by the host. More importantly, almost all
CSB mutations that cause CS continue to make the CSB-
PiggyBac fusion protein, whereas a mutation that com-
promises both does not cause CS. Thus the fusion protein
which is beneficial in the presence of functional CSB may
be harmful in its absence. This may help clarify the cause
of CS and other progerias.
CSB-PiggyBac Fusion Protein in CS
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immortalized CS1AN CSB fibroblasts rescued with CSB-wt
cDNA (CSB-wt line) or mock-rescued with enhanced green
fluorescent protein (CSB-null line) [25]. In all four lines, the
fusion transcripts were more abundant than the CSB transcripts
— as much as 13- to 26-fold more abundant in the immortalized
WI38 line (Figure S2).
The CSB-PGBD3 fusion transcript, apparently initiating at or
near the normal CSB start site, appears to be the only major
alternatively spliced transcript expressed from the CSB/PGBD3
gene. First, the transposase coding region is not an alternative
exon within full-length CSB mRNA, because combinations of two
upstream primers from the PiggyBac element and four down-
stream primers located in CSB exons 6, 7, 8 and 9 failed to
produce RT-PCR products in any of the four cell lines tested (data
not shown). Second, the CSB and CSB-PGBD3 transcripts lacking
exon 5 appear to be scarce (Figure 2, compare smaller and larger
bands in lanes 4–6 for CSB primer A and fusion primer D). And
third, as judged by Q-RT-PCR, the 39 region of the CSB mRNA
appears to be less abundant than the 59 region (data not shown),
arguing that the putative cryptic promoter within CSB exon 5 does
not generate significant quantities of an N-terminally truncated
CSB mRNA (DCSB, see Figure 1B).
Detection of the CSB-PGBD3 Fusion Protein
Consistent with the Q-RT-PCR data, we detected the CSB-
PGBD3 fusion protein in four different cell lines (HT1080, WI38/
hTERT, CSB-null and CSB-wt) by Western blotting with
antibodies specific for the N- and C-termini of CSB protein.
The C-terminal antibody revealed one major band of the size
expected for intact CSB protein (Figure 3A), whereas the N-
terminal antibody revealed two major bands — intact CSB and a
smaller band of approximately the size expected for the fusion
protein (Figure 3B). Notably, the fusion band was present in an
immortalized CSB-null line derived from the severely affected
individual CS1AN — a compound heterozygote consisting of one
CSB allele with an early truncating mutation (K337STOP) and a
second allele with a 100 nt deletion in exon 13 [38]. The latter
allele should, and does, permit normal expression of the fusion
protein in this CS cell line (Figure 3B). The fusion band was also
seen in the Saos-2 osteosarcoma and MRC5 fibroblast cell lines
(Figure S3).
To confirm the identity of the CSB-PGBD3 fusion band as
visualized with the N-terminal CSB antibody (Figure 3), we used a
commercial PGBD3-specific antibody. The PGBD3 antibody
revealed three major bands on Western blotting, including one
that comigrates with the fusion band (Figure 4). The CSB-PGBD3
fusion protein (with calculated mass 120 kDa and pI 6.15)
migrates more slowly than expected, but this is commonly
observed for acidic proteins [39], and the endogenous CSB-
PGBD3 fusion protein comigrates with recombinant tagged CSB-
PGBD3 fusion protein after correction for tag size (data not
shown). In contrast, CSB has a calculated pI of 8.2 and migrates as
expected for a mass of 168 kDa. We conclude that the endogenous
protein reacting with both N-terminal CSB antibody (Figure 3)
and the PGBD3-specific antibody (Figure 4) is the abundant CSB-
PGBD3 fusion protein.
The CSB-Transposase Fusion Protein is Expressed in
Primary CS Cells
A tabulation of all reported CS cases with known mutations in
CSB reveals that 21 of 24 retain at least one allele that should
Figure 1. The PiggyBac Element PGBD3 and the CSB-PGBD3 Fusion Transcript. (A) PGBD3 is located in intron 5 of the CSB gene, and appears
to be independently transcribed from a cryptic promoter within CSB exon 5. PGBD3 contains a 39 splice site in frame with the 59 splice site of CSB exon
5, and a polyadenylation signal (exon, upper case; intron, lower case). The element is flanked by a target site TTAA duplication just outside the left
(100 nt) and right (40 nt) split ends of a MER85 repeat element (gray lines, not to scale) with 13 nt terminal inverted repeats (gray arrows, not to
scale). (B) The 3.4 kb CSB-PGBD3 fusion transcript encodes a protein of 1061 amino acids, including the 465 N-terminal residues of CSB — up to but
not including the central ATPase motifs (Roman numerals) — and the entire PGBD3 transposase. Two transcripts may be generated from the cryptic
promoter with exon 5: The PGBD3 transposase, and a potential N-terminally deleted CSB transcript (DCSB). Absence of an early start codon suggests
that translation of the latter would begin within the first ATPase motif. Thin lines denote 59 untranslated sequence.
doi:10.1371/journal.pgen.1000031.g001
CSB-PiggyBac Fusion Protein in CS
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(Table S1). To confirm that CS cells express the fusion protein in
the absence of intact CSB, as seen for the hTERT-immortalized
CS1AN line (Figure 3B), we screened three different primary CSB
cells (GM10903, GM10905, and GM00739B derived from patient
CS1AN) none of which, as expected, exhibited intact CSB protein.
All, however, express the fusion protein (Figure 5). Nor is
expression an artifact of immortalization, as the abundance of
the fusion protein was similar in primary GM00739B cells
(Figure 5) and derived cell lines immortalized either with hTERT
(Figure 2, GM00739B) or SV40 (Figure S3, CS1AN/SV).
The CSB-PGBD3 Fusion Protein Sequence and Splice Sites
are Conserved in Primates
We were able to identify clear chimpanzee (Pan troglodytes) and
Rhesus macaque (Macaca mulatta) homologs of PGBD3 and all four
of the pseudogenes by BLASTing the PGBD3 coding region
against the recently-completed chimpanzee [40] and Rhesus [41]
genomes. We also identified homologs of CSB and PGBD3 in early
assemblies of the orangutan (Pongo abelli) and white tufted-ear
marmoset (Callithrix jacchus) genomes (Figure 6). All of these
sequences predict that PGBD3 will function as an alternative 39
terminal exon to generate a CSB-PGBD3 fusion protein.
Figure 2. The Extent and Abundance of the CSB-PGBD3 Fusion Transcript Assayed by Quantitative Real-Time RT-PCR. (A) Location of
six upstream primer sites, common to both the CSB and CSB-PGBD3 fusion transcripts; and three downstream primer sites specific to each transcript.
(B) Most of the tested primer pairs generated clean PCR products of the predicted size; identity was verified by sequencing. The smaller products
generated by primers A, D, E and F appear to be alternatively spliced transcripts lacking the 745 nt CSB exon 5; these transcripts are not predicted to
encode a functional protein. The products of the 40-cycle real-time protocol were resolved by 1% agarose gel electrophoresis. K, Invitrogen 1 kb
ladder; C, NEB 100 bp ladder; markers in bp.
doi:10.1371/journal.pgen.1000031.g002
CSB-PiggyBac Fusion Protein in CS
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identical to their human counterparts overall [40], and this was
true for the four PGBD3 pseudogenes and the 2 kb intronic regions
immediately flanking the PGBD3 coding region in CSB intron 5
(Table 1). As expected, the CSB protein coding region was more
highly conserved between chimpanzee and human (99.5% DNA
identity) than adjacent noncoding sequences. The PGBD3 coding
region was also much more highly conserved than noncoding
sequence (99.7% DNA identity). For both genes, the degree of
conservation lies outside the 95% confidence interval generated
from the six noncoding regions we analyzed (98.4–99.3%, see
Table 1). This was true for all four primate species examined —
for example, PGDB3 in marmoset, which last shared a common
ancestor with humans approximately 43 Mya [36], is 96.1%
identical in nucleotide sequence and 96.5% identical in amino acid
sequence to its human homolog, compared to 95.2% and 94.1%,
respectively, for CSB and 85.0–88.5% for noncoding nucleotide
sequence (Table 1).
A complementary method to estimate the degree to which a
protein coding sequence is under purifying selection is to calculate
the ratio of nonsynonymous (Ka, residue-altering) to synonymous
(Ks, silent) nucleotide substitution rates; a low ratio suggests that
the amino acid sequence is under strong purifying selection. We
analyzed CSB and PGBD3 coding sequences from human, chimp,
orangutan, Rhesus and marmoset with the SNAP program [42],
which implements the Ka/Ks algorithm of Nei et al. [43]. For
comparison, the decayed PGBD3 pseudogenes PGBD3P1 and
PGBD3P3 have mean Ka/Ks values of 0.73 and 0.96, respectively,
for pairwise comparisons between the various primate species
(Table 2). CSB, presumably under purifying selection, has a mean
Ka/Ks value of 0.21 (P,0.0001 vs. both P1 and P3). The mean Ka/
Ks for PGBD3 is 0.12 (P,0.0001 vs. both P1 and P3), consistent
with the transposase being subject to purifying selection at least as
strong as that for CSB. In fact, the mean Ka/Ks of PGBD3 is
significantly lower than that of CSB (P=0.0006), though the
difference between the entire fusion protein and CSB is not
significant (P=0.12).
We did not find a CSB-PGBD3 homolog in the draft genome
assemblies of two more distantly-related primates of the Strepsirrhini
family: galago (Otolemur garnetti) and mouse lemur (Microcebus
murinus), though the former may offer insights into the emergence
of PGBD3. The mouse lemur genome contained no recognizable
PGBD3 or MER85 elements. However, we found dozens of
examples of each in galago although the two species diverged from
a common ancestor only after the Strepsirrhini lineage separated
from that of humans and marmosets (Figure 6) [44]. Despite this
Figure 3. CSB-PGBD3 Fusion Protein Identified by Anti-CSB
Western Blotting. (A) Western blot using a C-terminal antibody
against CSB reveals the expected 170 kDa major band for full length
CSB (filled arrowhead). CSB is weakly expressed in hTERT-immortalized
WI38 cells, but not at all in hTERT-immortalized CS1AN cells (CSB-null)
until rescue with CSB cDNA (CSB-wt). (B) Western blot using an N-
terminal antibody against CSB reveals both full length CSB (filled
arrowhead) and, in all cell lines, a second major band of approximately
140 kDa (hollow arrowhead) that we identify in Figure 4 as a CSB-
PGBD3 fusion protein. The fusion protein is more abundant than CSB in
WI38/hTERT cells, and is strongly expressed in immortalized CS1AN cells
before and after rescue. CS1AN is a compound heterozygote line; one
CSB allele contains an early truncating mutation (K337STOP) but a
second allele with a 100 nt deletion in exon 13 should permit
expression of the fusion protein. CSB and the CSB-PGBD3 fusion
protein both migrate more slowly than predicted based on molecular
mass alone, presumably due to the N-terminal acidic domain (see text).
Markers in kDa.
doi:10.1371/journal.pgen.1000031.g003
Figure 4. CSB-PGBD3 Fusion Protein Reacts with Anti-PGBD3
Antibody. Western blot of HT1080 extracts using CSB C-terminal and
N-terminal antibodies, and a commercial antipeptide antibody to
PGBD3. The PGBD3 antibody reacts with the same 140 kDa band as the
N-terminal CSB antibody. CSB decreases relative to CSB-PGBD3 fusion
protein as cells approach confluence; compare logarithmically growing
HT1080 (Figure 3B, leftmost lane) with confluent cells (Figure 4, middle
panel). The lower band on the PGBD3 panel is likely PGBD3 itself
(predicted 68 kDa, presumably initiating at the cryptic promoter within
CSB exon 5), while the middle 105 kDa band may reflect crossreaction
with PGBD1 (predicted 93 kDa) which contains a region homologous to
the peptide epitope. Markers in kDa.
doi:10.1371/journal.pgen.1000031.g004
CSB-PiggyBac Fusion Protein in CS
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target site in galago CSB intron 5 is intact and empty. Moreover, of
the eight galago PGBD3-like sequences we examined in detail, all
are in an advanced state of decay, and all but one are more closely
related to human PGBD3 than to each other (Table S2).
Interestingly, a consensus sequence of galago PGBD3’s is as similar
to human PGBD3 (87.8% identity) as galago CSB exon sequences
are to their human counterparts (87.6% identity), and both are
significantly more identical than the individual PGBD3-like
elements are to human PGBD3 (see Table S2 for confidence
intervals) - suggesting that the ancestor of these galago PGBD3-like
sequences was closely related to conserved human PGBD3. The
galago PGBD3’s are equally similar to human PGBD3 and this
consensus (P=0.61 by paired Student’s T-test, see Table S2),
consistent with divergence from a closely related ancestor.
Together, these data suggest that an element closely related to
the ancestral human PGBD3 independently invaded the galago
and human-marmoset lineages. Though invasion of the common
galago-human ancestor by ancestral PGBD3 would also explain
the PGBD3-like sequences in galago, the monophyly of Strepsirrhini
is well accepted [44] and it is unlikely that all traces of PGBD3 and
MER85 would have been eradicated from the mouse lemur
genome given their abundance in all genomes in which they are
found. We conclude that an ancestral PGBD3 element invaded
CSB intron 5 at least 43 Mya, before human and marmoset
diverged [36]; PGBD3 was then conserved in the human-
marmoset lineage because the CSB-PGBD3 fusion protein
performs a selectable function (see Discussion) whereas the
elements ultimately degenerated in galago where the random
transpositions were either neutral or harmful.
PiggyBac Survives as a Natural ‘‘Exon Trap’’
The PiggyBac element has the hallmarks of a transposable
element that has survived through evolution by functioning as a
natural ‘‘exon trap’’. In both cabbage looper moth and primates, the
transposase ORF is flanked immediately upstream by a potential 39
splice site (TTTTCTTGTTATAG in moth PiggyBac,C C T T T T -
TTCCGTTTTAG in PGBD3) and immediately downstream by a
potential polyadenylation signal (AATAAATAAATAAA in moth
PiggyBac,A A T A A Ai nPGBD3). This 39 splice site is perfectly
conserved between human, chimpanzee, Rhesus, orangutan and
marmoset (Figure S4), and in all five species PGBD3 possesses a
potential polyadenylation signal (Figure S5) despite evidence for
strong selection against transcription of intragenic transposable
elements [45]. Insertion of an element with these features into a host
intron can generate an N-terminal fusion protein as observed for the
PGBD3 insertion into CSB intron 5 (Figure 1). Similarly, PGBD1 and
PGBD2, which are present in mouse and rat (though reduced to
pseudogenes in mouse), also appear to have persisted as exon traps:
The RefSeq human mRNAs include multiple upstream exons
derived from the host gene, with the intact transposase encoded
within a single large 39 terminal exon. Indeed, the ability of the T. ni
PiggyBac transposase to tolerate N-terminal fusions unlike the
Sleeping Beauty,Tol2, and Mos1transposases [15] isconsistent with
the genomic evidence that PiggyBac evolved as a 39 terminal exon
trap.Evolutionasa39exontrapmayalsoexplaintheimpressivehost
range of T. ni PiggyBac [46] because transcription of the element is
driven by an efficient host promoter, instead of relying on fortuitous
promoters or a universal species-independent promoter internal to
the element itself.
MER Elements and the Domestication of PGBD3
In contrast to PGBD3, the four PGBD3-related pseudogenes are
all in an advanced state of decay (88–90% identity to PGBD3; see
Figure S6). None of the pseudogenes contains an ORF longer than
62 codons and three exhibit major deletions or rearrangements.
All are more closely related to PGBD3 than to any of the other
pseudogenes (Table S3), suggesting that all diverged from PGBD3
itself or from a closely related common ancestor before the
divergence of the human and Rhesus lineages. The left and right
ends of PGBD3 correspond to the left (100 nt) and right (40 nt)
halves of the 140 nt MER85 repeat element [47], an arrangement
also found in the four human PGBD3 pseudogenes. We found 613
examples of MER85 elements in the human genome; in almost all
cases, these were either intact left ends (403), intact right ends (119)
or complete 140 nt elements (73). MER85 has been described as a
nonautonomous transposable element derived from PiggyBac and
presumably mobilized in trans by the PiggyBac transposase [1];
many other transposons have given rise to similar nonautonomous
elements known collectively as ‘‘miniature inverted repeat
transposable elements’’ or MITEs [12]. The similarly abundant
MER75 and MER75B elements appear to be derived from
PGBD4, although the PGBD4 transposase exon is no longer neatly
flanked by its derivative elements as PGBD3 is by MER85.
Figure 5. CSB-PGBD3 Fusion Protein in Primary CS Cells
Lacking Intact CSB. Western blots using an N-terminal CSB antibody
reveal only the fusion protein (hollow arrowhead) and not full-length
CSB (filled arrowhead) in three different primary CSB cells. GM00739B is
derived from patient CS1AN and is the parent of our hTERT-
immortalized derivatives (CSB-wt and CSB-null lines), thus demonstrat-
ing that the fusion protein is not an artifact of immortalization.
GM10903 and GM10905 are from two patients diagnosed with the
DeSanctis-Cacchione variant of XP (XP-DSC; XP61SF and XP63SF in
Table S1). The clinical overlap between CSB/XP-DSC and CSB/CS is
substantial, including photosensitivity (but not skin cancers), mental
retardation and severe growth failure [77]; in fact, the same
homozygous R735STOP mutation shared by both patients is also
associated with classical CS in another patient (CS1TAN). A broad
unidentified band or doublet of about 100 kDa (asterisk) is seen in the
primary lines (GM00739B, GM10903, and GM10905) but is absent when
cells are spontaneously transformed (MRC5) or immortalized by SV40
(Figure S3) or hTERT (Figure 3).
doi:10.1371/journal.pgen.1000031.g005
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MER85 has been significantly mobile since the divergence of
human, chimpanzee and Rhesus. We found that 36 of 42 MER85
elements on human chromosome 1 had clear homologs on
chromosome 1 of at least one of the other primates, as did 20 of 21
human MER75B elements. The few remaining unmatched human
elements likely reflect incomplete sequences or recombination.
Most PiggyBac transposases have three conserved aspartic acid
residues [13] which may be related to the metal-coordinating
DDE motif found in the catalytic domain of many transposase and
integrase families [49]. The most likely candidates for these
conserved residues in PGBD3 [13] are identical in all five primates
(human, chimp, orangutan, Rhesus and marmoset): D270, N352
and D467 (Figure S7). Strikingly, all four pseudogenes in human,
chimp and Rhesus encode D at the second position (the draft
orangutan and marmoset genomes do not yet include all PGBD3
pseudogenes). Half of the galago PGBD3-like sequences we
examined also encode D at this position, while the remainder
harbor one of several changes (Figure S8). Together, this suggests
that the feral ancestor of human PGBD3 encoded a DDD motif,
and that its domestication involved mutations that compromised
mobility.
Figure 6. Phylogeny of PGBD3 and the CSB-PGBD3 Fusion Protein. PGBD3 inserted into the CSB gene prior to the divergence of human and
marmoset approximately 43 Mya, and has been highly conserved in all members of this lineage. An element very similar to ancestral PGBD3 also invaded
thegalago genome afterthe divergenceofgalago from itsStrepsirrhinirelative,mouselemur. Treebeginswiththe Euarchontoglinescommonancestor. In
addition to mouse, rat, rabbit and tree shrew, we searched for but did not find PGBD3 or MER85 in the assembled genomes of non-Euarchontoglines
placental mammals (horse, cat, dog, cow, pig and sheep), nor in the more distantly related marsupial opossum and monotreme platypus. Arrowheads
mark possible date of PGBD3 invasions: As described in the text, the similarity of the galago consensus PGBD3 sequence to human PGBD3 suggests a
contemporaryoriginfortheelements,likelyafterthedivergenceofgalagoandmouselemur(57 Mya)butbeforethedivergenceofmarmosetandhuman
(43 Mya). Approximate dates of divergence for primates are from Steiper et al. [78] and for non-primates from Springer et al. [79].
doi:10.1371/journal.pgen.1000031.g006












1 99.5 98.5 97.2 95.2
PGBD3 coding cDNA 99.7 99.0 98.6 96.1
2 kb upstream of PGBD3 within CSB intron 5
2 98.9 97.2 93.2 87.2
2 kb downstream of PGBD3 within CSB intron 5
2 98.9 97.4 94.4 88.1
PGBD3P1 98.7 94.7 87.9 n/p
PGBD3P2 99.2 n/p 92.0 n/p
PGBD3P3(+)
3 98.0 94.9 88.4 84.9
PGBD3P3(2)
3 99.2 n/p 93.6 n/p
PGBD3P4 98.9 n/p 91.2 n/p
CSB protein 99.3 98.0 97.3 94.1
PGBD3 protein 99.7 99.3 98.8 96.5
Mean and (95% CI) of identity for six noncoding sequences 98.8 (98.4–99.3) 96.1 (94.5–97.6) 91.5 (88.9–94.2) 86.7 (85.0–88.5)
1We compiled CSB coding cDNA sequence by mapping the human cDNA to primate genomic sequences.
22 kb of intron sequence was analyzed beginning immediately upstream and downstream of the inverted repeats flanking PGBD3.
3The 39 half of PGBD3P3 is inverted in human, chimp and Rhesus; conservation was calculated separately for the 59 (+)a n d3 9 (2) portions of the pseudogenes.
4Orangutan genome assembly includes sequencing gaps that obscure 380 nt of the latter portion of CSB exon 18 and 55 nt of PGBD3; these regions were omitted from
identity calculations.
n/p, Not present in draft genome assembly.
doi:10.1371/journal.pgen.1000031.t001
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The exapted mariner transposase in the SETMAR fusion protein
retains ancestral DNA binding activity despite attenuation or loss
of transposase function [9]. We therefore asked whether genes
located closest to MER85 elements might exhibit common themes
or functions possibly reflecting a cis-regulatory function of the
MER85 elements themselves or proteins that bind to them [50].
Using the ENSEMBL gene database, we located the transcription
start site closest to each identified MER85 element (Table S4). The
median distance between MER85 elements and transcription
starts was 93 kb, similar to what is seen for other human repeats
present in 500 to 4,000 copies [51]. Of the 613 MER85 elements,
we selected the 585 that were less than 1 Mb from a transcription
start site, well within the documented range of proximal enhancer
elements [52]. We then used the L2L Microarray Analysis Tool
[53] to search for expression patterns among these MER85-
associated genes (Table S5). The strongest pattern to emerge was a
striking similarity to genes down-regulated by UV irradiation in
both normal and repair-deficient (XPB/CS, XPB/TTD) cells:
Nine lists overlapped with P,0.02, and there was no similar
finding among 1000 random-data simulations (Table S6).
Intriguingly, the list of MER85-associated genes also overlapped
significantly with the list of genes we had previously shown to be
down-regulated by CSB (P=0.012; corrected to P=0.015 by
random-data simulation) when hTERT-immortalized CSB-wt and
CSB-null cell lines are compared [25]. There was no similar
overlap with genes up-regulated by CSB. The most enriched Gene
Ontology term was the Molecular Function ‘‘Glutamate Receptor
Activity’’ (Table S7) reflecting association of MER85 with six
glutamate receptors (GRM7, GRID1, GRID2, GRIK2, GRIN2A
and GRIN2B) and two related GPCRs (7-fold enrichment,
P=1.6e-5; no similar finding among 1000 random-data simula-
tions). Similar glutamate-related terms were the most enriched in
the other Gene Ontology categories as well (data not shown).
Discussion
We provide a combination of genomic, genetic, mRNA, and
protein evidence that a CSB-PGBD3 fusion protein, generated by
alternative splicing of CSB exon 5 to a PGBD3 transposon within
intron 5, is a major product of the CSB/PGBD3 locus; that the fusion
protein has been highly conserved in primates since the transposon
was domesticated at least 43 Mya; that the fusion protein continues
to be expressed in primary cells from three CS patients who lack
functional CSB; and that nearly all CS-causing CSB mutations are
locateddownstreamoftheexon5/6boundaryintheATPaseandC-
terminal domains of CSB protein, with the result that the fusion
protein is predicted to be expressed in at least 21 of 24 characterized
CS cell lines lacking functional CSB. The alternatively spliced CSB-
PGBD3 mRNA was readily detectable by Q-RT-PCR, and was
more abundant in all cell lines tested than full length CSB mRNA;
the fusion mRNA had also been observed over a decade ago as an
unexplained 3.4 kb polyadenylated RNA reacting with probes for
the 59 end but not the central region of CSB mRNA [54]. Consistent
with our Q-RT-PCR data, we found by Western blotting that the
CSB-PGBD3 fusion protein is abundant in a variety of primary and
established CS and non-CS cells, and reacts as expected with both
N-terminal CSB antibodies and a PGBD3-specific antibody.
The CSB-PGBD3 Fusion Protein May Contribute to
Cockayne Syndrome
Three mysteries have shaped thinking about Cockayne
syndrome. First, the complete absence of CSB protein apparently
does not cause CS, but rather a mild UV-sensitive syndrome with
no developmental symptoms [33]. Yet all disease-associated CSB
alleles identified to date are recessive; no dominant mutations are
known. Second, nearly all CSB mutations that cause CS are
located downstream of the exon 5/6 boundary (codon 466) in the
ATPase and C-terminal regions of the 1493 residue protein
(Figure 7; see Table S1 for details). And third, mouse models with
either a truncating mutation similar to a severe human CSB allele
(CS1AN; K337STOP) [55] or a CSA knockout [56] manifest the
characteristic UV sensitivity of CS, as well as an unexpected
susceptibility to skin cancer not observed for human CSB and CSA
mutations, but only a subtle developmental phenotype. However,
when the CSB defect is combined with an additional defect in an
NER-GGR factor (XPC [57] or XPA [58]), mouse models do
recapitulate the full CS-like phenotype including growth retarda-
tion, neurological dysfunction, and reduced life span.
The conserved CSB-PGBD3 fusion protein is expressed in both
primary and established CS cells (Figures 2, 3, 5, and Figure S3),
and could explain these mysteries if the fusion protein, which is
advantageous in the presence of functional CSB (Tables 1 and 2),
were detrimental in its absence. According to this hypothesis,
mutations downstream of CSB exon 5 would cause CS by
impairing expression of functional CSB without affecting expres-
sion of the fusion protein; nonsense and frameshift mutations
upstream of exon 6 would not cause CS [33] because they would
also abolish expression of the fusion protein; mutations that do
cause CS would be recessive because functional CSB masks the
effects of the CSB-PGBD3 fusion protein; and mouse models of
severe CSB mutations or a CSA knockout would not exhibit the full
range of CS symptoms because rodents lack the PGBD3 insertion
that generates the CSB-PGBD3 fusion protein.
Consistent with this hypothesis, 21 of the 24 molecularly
characterized CS genotypes appear capable of expressing the
CSB-PGBD3 fusion protein (Figure 7 and Table S1). We have also
confirmed experimentally that the fusion protein continues to be
Table 2. Ka/Ks Ratios for CSB and PGBD3 between Primate Species.
Human-chimp Human-orangutan Human-Rhesus Human-marmoset
Mean of all ten* primate-
primate comparisons (95% CI)
CSB 0.25 0.32 0.14 0.20 0.21 (0.18–0.25)
PGBD3 0.14 0.06 0.13 0.14 0.12 (0.10–0.14)
CSB-PGBD3 fusion 0.19 0.18 0.18 0.19 0.18 (0.17–0.19)
PGBD3P1 0.46 0.73 0.91 n/p 0.73 (0.63–0.83)
PGBD3P3 0.83 0.57 1.43 0.69 0.96 (0.73–1.2)
*Six comparisons for PGBD3P1, which is not present in the marmoset genome draft.
doi:10.1371/journal.pgen.1000031.t002
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(Figure 5) including patient CS1AN whose CSB genotype is known
(Table S1). Only 3 of the 24 CS genotypes appear, on first sight, to
be unable to express the fusion protein: the R453opal mutation
found in first cousins CS1PV and CS3PV [59], and the +T1359
insertion mutation in patient CS10LO which causes a frameshift
at residue 427 and termination at residue 435 [60]. However, all 3
of these CS genotypes could conceivably generate detectable levels
of the CSB-PGBD3 fusion protein. UGA codons are often leaky
[61] and can be suppressed by several natural tRNAs [62,63].
Similarly, the existence and varying efficiency of programmed +1
and 21 frameshifting [64] suggests that frameshift mutations may
sometimes be subject to a compensatory ribosomal frameshift that
partially preserves the original reading frame. Indeed, ribosomal
frameshifting is strongly dependent on context [65] which appears
to be very ‘‘slippery’’ in the case of the +T1359 mutation (TTT
TTC CCA to TTT TTT CCC) and could in principle increase
the frequency of +1 frameshifts. Of course, leaky terminators and
weak frameshifts might have been expected to rescue expression of
both the CSB-PGBD3 fusion and full length CSB protein, but it
should be kept in mind that the CSB-PGBD3 and CSB mRNAs are
alternatively spliced and polyadenylated transcripts with different
intron/exon structures and different 39 UTRs. The role of mRNA
context and intron/exon structure in nonsense-mediated decay is
still not fully resolved [66] and it is possible that the same mutation
could differentially affect translation or degradation of the CSB
and CSB-PGBD3 mRNAs. Alternatively, the 3 anomalous patients
(CS1PV, CS3PV, and CS10LO) may not express the fusion
protein, but have other mutations or modifier genes which
phenocopy the effect of the fusion protein.
If the CSB-PGBD3 fusion protein does indeed play a role in CS,
the complex clinical presentation of the disease [26] might be
explained by variable expression of the fusion protein in different
individuals and cell types (Figure S3), or by the degree or nature of
residual CSB activity. CS and genetically related syndromes like
cerebro-oculo-facio-skeletal syndrome (COFS) and the DeSanctis-
Cacchione variant of xeroderma pigmentosum (XP-DSC) could
also be multifactorial, requiring two or more ‘‘hits’’ or perhaps
modifier genes — consistent with mouse models showing that a
CSB defect must be combined with a second defect in an NER-
GGR factor (XPC [57] or XPA [58]) to generate a strong
developmental phenotype.
A highly conserved and abundant protein which shares the first
5 exons of CSB is very likely to affect CSB-related cellular
functions, but detailed functional characterization of the fusion
protein will be required to understand how it could be detrimental
in the absence of functional CSB protein. Unlike the ATPase
domain of CSB encoded by sequences beyond the exon 5/6
boundary (Figure 1B) which is essential for DNA repair and
chromatin remodeling, the N-terminal region encoded by CSB
exons 1–5 is less well conserved and is apparently not essential
either for transcription-coupled repair (TCR) or global genome
repair (GGR) of UV-induced or bulky lesions [67]. Nonetheless,
the possibility remains that in the absence of CSB, DNA repair
complexes might recruit the CSB-PGBD3 fusion protein instead,
blocking chromatin remodeling after attempted repair, preventing
redundant repair pathways from accessing the damage, seques-
tering key repair factors, or even damaging the DNA if attempted
repairs cannot be completed. This could also explain why CSA
mutations are clinically indistinguishable from CSB mutations:
Failure of CSA to target CSB [68] for ubiquitin-dependent
degradation after CSB-dependent repair could have the same
effect as the fusion protein in the absence of CSB — freezing
repair complexes in place, and blocking subsequent events.
Moreover, if the PGBD3 domain of the fusion protein targets
CSB-dependent chromatin remodeling complexes to MER85
elements, loss of CSB might affect regulation of MER85-associated
genes (Tables S4, S5, S6, S7) or enable MER85 elements
themselves to sequester chromatin remodeling factors.
Conservation of the Fusion Protein in Primate Lineages
The PGBD3 element in intron 5 of the CSB gene has not only
been conserved for at least 43 Mya from marmoset to human, but
the PGBD3 element itself is at least as highly conserved as
surrounding CSB sequences (Table 1). Moreover, synonymous
changes are at least as abundant for PGBD3 as for CSB in the
human, chimp, orangutan, Rhesus and marmoset protein coding
sequences (Table 2). We conclude that the initial PGBD3 insertion
was selected for a new function advantageous to the primate host,
and the CSB-PGBD3 fusion protein was thereafter subject to
purifying selection to prevent loss of function.
The high correlation of homologous MER85 insertions in
human, chimpanzee and Rhesus macaque on chromosome 1, and
the absence of any lineage-specific PGBD3 pseudogenes, suggests
that neither PGBD3 nor the related MER85 elements have been
mobile since the three lineages diverged. These findings are
consistent with several recent studies: an analysis of MER85 and
MER75 sequence divergence by the Human Genome Sequencing
Figure 7. Schematic of CSB Mutations Associated with Human Disease. Of 24 patients with known CSB geneotypes and CS, COFS, or XP-DSC
phenotypes, 21 have at least one allele that is predicted to express intact CSB-PGBD3 fusion protein. For each patient, the allele with the more C-
terminal mutation is shown (e.g. patient CS1AN is a compound heterozygote for K337STOP and del834-866; only the latter is shown here). Some
mutations are found in several patients. The location of the homozygous UV
sS mutation that causes UV sensitivity but not CS [33] is shown for
comparison. See Table S1 for a list of all patients and alleles. fs, frameshift; del, deletion; *, STOP. Red box is the CSB acidic domain; blue boxes are the
ATPase subdomains.
doi:10.1371/journal.pgen.1000031.g007
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within the human, chimpanzee and Rhesus genomes [69], and an
exhaustive study of DNA transposon activity in primates using
ENCODE project genomic sequences [48]. The consistent D352
versus N352 difference in the putative catalytic DDD motif between
decaying pseudogenesandPGBD3 itselfinallspecies(FiguresS7and
S8) suggests that this change may have been critical for both the
stability of PGBD3 within CSB and for the demobilization of PGBD-
related pseudogenes and MER elements derived from them. The
same appears to be true for the domesticated mariner transposase of
the SETMAR fusion protein where the catalytic DDD triad has
mutated to DDN [9]. We speculate that both the PGBD3
pseudogenes and the abundant MER85 elements are relics of a
brief burst of activity when the PGBD3 transposon,newly introduced
into anancestral primategenome,replicatedwithout hindrance, and
both spawned and propagated dependent MER elements.
Although complete and intact PGBD transposons are rare in all
genomes examined [13], the abundance of MER elements
suggests that infection of the primate lineage had the potential
to get out of control. Indeed, the apparent independent infection
of galago, whether by horizontal transfer from the contemporary
human-marmoset ancestor or from an external source, and the
dozens of degenerate PGBD3-like sequences generated by this
infection, highlight the virulence of feral PGBD3. Insertional
mutagenesis may have been the least of the dangers, as multiplying
MER elements could have provided targets for genomic
rearrangements mediated by the PGBD3 transposase — a well
documented phenomenon for other DNA transposons with
terminal inverted repeats such as Drosophila P-elements [70].
Domestication (i.e., insertion and fixation) of PGBD3 within the
CSB gene may have been the genetic response that restored
genomic stability. Indeed, recruitment of the offending transposase
itself in the form of a fusion protein has obvious advantages: The
attenuated or inactivated transposase may simply occupy and
occlude binding sites for the normal transposase — much as the
absence of a germline-specific mRNA splice transforms the
Drosophila P-element transposase into a somatic repressor of
transposition [71] — or the fusion protein may actively guide
host defense complexes to potential sites of excision, insertion, or
rearrangement. It is also interesting to note that the S. cerevisiae
homolog of XPD, known as Rad3, inhibits Ty1 retrotransposition
[72]. CSB binds to several TFIIH subunits including XPD [17],
suggesting a possible role for the N-terminal CSB domain of the
CSB-PGBD3 fusion protein in silencing PGBD3 family elements.
Clues to a MER85 Gene Regulatory Network
Repression of PiggyBac and/or MER85 mobility may explain
the initial domestication of PGBD3 more than 43 Mya, but the
CSB-PGBD3 fusion protein continues to be conserved and
abundantly expressed in primates despite the passage of sufficient
time to inactivate existing PGBD-related transposases. This
suggests that the CSB-PGBD3 fusion protein may now be
conserved for a new or secondary function. Noncoding elements
account for the much of the genomic sequence under purifying
selection in mammals [73], and many of these conserved
noncoding sequences may be remnants of ancient transposons
[50,51]. The exaptation of SETMAR, fusing a SET histone
methyltransferase domain to a mariner-like transposase, may have
marked the emergence of a novel regulatory network based upon
thousands of preexisting and now-selectable mariner elements [9].
Indeed, the exaptation of DNA-binding transposases has been
proposed by Feschotte and Pritham [74] as ‘‘a pervasive pathway
to create a genetic network [from] unlinked binding sites
previously dispersed in the genome’’. Our analysis of the genes
closest to MER85 elements (Table S4) suggests that the CSB-
PGBD3 fusion protein may have created just such a regulatory
network based on MER85 elements. We had previously shown by
expression microarray analysis that CSB protein has a general
chromatin remodeling function which includes the maintenance of
transcriptional silencing; specifically, loss of CSB phenocopied
conditions that disrupt chromatin structure such as treatment with
inhibitors of histone deacetylation and DNA methylation, and
defects in poly(ADP-ribose)-polymerase [25]. Surprisingly, many
of the CSB-repressed genes are associated with MER85 elements
(Table S5, ‘‘csb_reliable_up’’ database list). Just as striking was the
association of MER85 elements with genes that are repressed
following UV irradiation (Tables S5 and S6); UV is known to
cause nuclear translocation of CSA [75] which may in turn be
required for full CSB function. Thus, recruitment of CSB or CSB-
associated factors to MER85 elements by the CSB-PGBD3 fusion
protein, perhaps in combination with independently transcribed
PGBD3 transposase (Figures 1 and 4), may not only inhibit
PGBD-mediated transposition, but also transcription of neighbor-
ing genes. The overabundance of neuronal genes — specifically
glutamate receptors — among those closest to MER85 elements
(Table S7) is particularly intriguing because CS exhibits a strong
neurodegenerative component. Sarkar et al. [13] note that the
independent domestication of PiggyBac in nearly all metazoan
lineages suggests that these transposable elements ‘‘have repeat-
edly been turned to advantage by the host.’’ We suggest that this is
a natural consequence of the PiggyBac lifestyle as a 39 terminal
exon trap in which the transposase ORF is flanked by 39 splice site
and polyadenylation signals (Figure 1 and Figures S4 and S5), and
the activity of the transposase protein readily tolerates N-terminal
fusions [15]. We do not yet know why the CSB-PGBD3 fusion
protein has been selected and maintained in the primate lineage
for over 43 My, but the answers will undoubtedly shed light on
both CSB function and the longevity of PiggyBac transposases
from cabbage looper moths to humans [13].
Materials and Methods
Cell Lines and Culture Conditions
HT1080 (human fibrosarcoma), MRC5 (human embryonic lung
fibroblast) and Saos-2 (human osteosarcoma) cell lines, along with
primary CScells GM0010903and GM0010905 wereobtained from
repositories. WI38 human embryonic lung fibroblasts were immor-
talized by PG-13/neo retroviral transduction of hTERT cDNA
[76]. Immortalized CSB (CS1AN) fibroblasts expressing either wild-
type CSBcDNA(CSB-wt line)orenhancedgreenfluorescent protein
(CSB-null line) were generated as described [25]. HeLa, WI38/
hTERT, and CS1AN-derived lines were cultured in MEMa media
with 10% fetal bovine serum plus supplements (Gibco). Selection for
expression ofhTERT, CSB, and enhanced greenfluorescentprotein
was maintained with 1 mg/ml G418 and 0.5 mg/ml puromycin,
respectively. Cells were passaged by a wash in Puck’s EDTA
followed by trypsinization. HT1080 cells were cultured in MEMa
media with 10% fetal bovine serum, and passaged by a wash in PBS
followed by trypsinization.
Real-Time Quantitative RT-PCR
Total RNA was harvested directly from adherent cells with
Trizol reagent (Ambion). Synthesis of cDNA was primed with
oligo(dT) and carried out using Superscript II reverse transcriptase
(Invitrogen). Each real-time reaction consisted of cDNA template
from 20–50 ng of total RNA, 300 nM 59 and 39 gene-specific
primers, and 16SYBR Green master mix (Applied Biosystems) in
20 ml total reaction volume. All reactions were performed in
CSB-PiggyBac Fusion Protein in CS
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(MJ Research). Relative differential expression was calculated from
mean threshold cycle difference among the three replicate
reactions. Products were visualized by pooling the three replicate
reactions, purifying and concentrating over a QIAquick column
(Qiagen), and running half of the total sample on a 1.0% agarose
gel stained with ethidium bromide. Primer sequences are available
on request.
Sequence Comparison of PiggyBac Genes
Pairwise alignments and comparisons of analogous sequences
were performed by Needleman-Wunsch global alignment, as
implemented in EMBOSS needle. Overhanging ends were excluded
from the identity calculations. We compared only homologous
sequence regions: For example, we ignored the truncations of
several PGBD3 pseudogenes when calculating their homology to
PGBD3. Coding region identity was calculated from translation
start to stop codons. Pseudogene identities were calculated from
the 39 SS (or start of homology) to the stop codon (or end of
homology). We used RepBase RepeatMasker to identify the flanking
MER85 and MER75B elements of PGBD3 and PGBD4,
respectively. To determine if the conservation of the PGBD3 and
CSB coding regions is statistically significant, we analyzed the
conservation of six noncoding sequences for comparison: 2 kb of
intron sequence beginning both immediately upstream and
downstream of the inverted repeats flanking PGBD3, and the four
PGBD3 pseudogenes. We determined the conservation of each of
these six sequences individually by pairwise alignment between
species using needle. We calculated a mean identity of all six and
then used the inverted t-distribution to generate a confidence
interval. The conservation of the PGBD3 and CSB coding regions
was considered significant if the identity fell outside the 95%
confidence interval of conservation for these six noncoding
regions; this calculation is not dependent on the length of the
query sequences. In order to determine whether MER85 and
MER75B elements have been mobile since the divergence of the
three primates, we used NCBI megaBLAST to identify all MER85
and MER75B elements on human, chimpanzee and Rhesus
chromosome 1 (June 2006 NCBI sequence releases), based on the
consensus sequence for these elements in RepBase Update [47].
We then extracted 1 kb of the surrounding sequence for each
element, and used EMBOSS needle to align every such human
sequence pairwise with every sequence from chimpanzee and
monkey. Marmoset (version 2.0.2, released June 2007) and
orangutan (version 2.0.2, released July 2007) preliminary genome
assemblies were downloaded from the Washington University
Genome Sequencing Center. Mouse lemur (draft v2, released June
2007), galago (draft v1, released June 2006) and tree shrew (draft
v1, released June 2006) genome sequences were downloaded from
the Broad Institute Mammalian Genome Project. Ka/Ks analysis
was performed using SNAP (Synonymous Nonsynonymous
Analysis Program) from the HIV Database at Los Alamos
National Laboratories (USA) [42]. The significance of differences
in Ka/Ks values was calculated with the Student’s T-test using a
two-tailed distribution and an assumption of unequal variance. All
sequences and alignments used in this study are available on
request.
Analysis of MER-Associated Genes
MER85 elements were identified in the March 2006 release of
the NCBI human genome sequence by using NCBI megaBLAST to
query each complete chromosome sequence for the RepBase
MER85 consensus sequence. The start site of each element was
matched to the closest start site of an HGNC-named gene from
the ENSEMBL database. The resulting list of genes, excluding
those located .1 Mb from their associated MER85 element, was
analyzed with the 2007.1 release of the L2L Microarray Analysis
Tool, including several unreleased lists representing CSB-regulat-
ed genes. The list of all HGNC-named genes in the ENSEMBL
database was used as the null set. The P values generated by L2L
were validated using random-data simulations as described
previously [25]. Briefly, we randomly selected 1000 lists of genes
from the null set, each the same size as the list of MER85-
associated genes, and ran each through an identical L2L analysis.
These random-data results were mined for the frequency of the
outcomes seen in the analysis of MER85-associated genes.
Western Blots
GM00739B/hTERT cells were transfected in 100 mm tissue
culture plates with 10 mg of plasmid constructs using 15 mlo f
Fugene 6 reagent (Roche). After 48 h, cells were washed with PBS
and harvested by scraping. Cell pellets were resuspended in 100 ml
of SDS loading buffer (25 mM Tris, pH 6.8, 2% SDS, 0.1%
bromephenol blue, 10% sucrose, 0.12 M b-mercaptoethanol),
sonicated to shear DNA, and denatured by heating at 95uC for
10 min. Non-transfected plates of HT1080 and WI-38/hTERT
cells were harvested in the same manner. Proteins were separated
on a 6% gel by SDS-PAGE using the Mini-Protean 3 Cell
(BioRad) in a Tris/glycine/SDS buffer (1.5 g/l Tris base, 7.2 g/l
glycine, 1% SDS). Proteins were transferred to a PDVF
membrane in 25 mM Tris, 192 mM glycine, and 20% methanol
buffer using a Mini Trans-Blot Cell (BioRad). After transfer, the
PVDF membranes were blocked for 2 h at room temperature in
TBST (50 mM Tris, pH 7.4, 150 mM NaCl, 0.05% Tween 20)
plus 5% nonfat dry milk. The membrane was then incubated at
room temperature in TBST plus 5% nonfat dry milk for 2 h with a
1:1000 dilution of primary antibody, washed twice for 10 min
each, incubated for 1 h with a 1:5000 dilution of HRP-conjugated
secondary antibody (Santa Cruz Biotechnology), and finally
washed 4 times for 10 min each in TBST alone. Chemilumines-
cent detection was performed using the ECL Plus
TM Western
Blotting Detection System (Amersham) and Kodak X-Omat Blue
film. Anti-CSB antibodies were generated in our laboratory as
rabbit polyclonals raised to the C-terminal 158 amino acids or N-
terminal 240 amino acids of CSB expressed as bacterial GST
fusion proteins. Anti-GST antibodies were removed from the
serum by passage over a GST column. Anti-PGBD3 antibody was
purchased from AVIVA Systems Biology, catalog number
ARP36534.
GenBank Accessions for Primate Sequences
Human PGBD3 and the four PGBD3 pseudogenes are present
in the NCBI Entrez Gene database, but have not yet been curated
in the chimpanzee or Rhesus genomes. The accessions and
approximate indicies for the coding region sequences used in this
study are as follows:
Chimpanzee
PGBD3: NW_112875 REGION: 1929225..1927305 (chr 10)
PGBD3P1: NW_114825 REGION: 5794955..5793042 (chr 12)
PGBD3P2: NW_107030 REGION: 2131567..2132809 (chr 5)
PGBD3P3: NW_114852 REGION: 191259..192848 (chr 12)
PGBD3P4: NW_105918 REGION: 8439037..8440924 (chr 4)
Rhesus
PGBD3: NW_001124201 REGION: 674139..676053 (chr 9)
PGBD3P1: NW_001096629 REGION: 99414..98334 (chr 11)
CSB-PiggyBac Fusion Protein in CS
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PGBD3P3: NW_001096663 REGION: 36134..37168 (chr 11)
PGBD3P4: NW_001118143 REGION: 11277269..11279192
(chr 5)
Supporting Information
Table S1 CSB mutations associated with human disease.
Found at: doi:10.1371/journal.pgen.1000031.s001 (0.06 MB
DOC)
Table S2 Comparison of galago PGBD3-like sequences with
human PGBD3.
Found at: doi:10.1371/journal.pgen.1000031.s002 (0.06 MB
DOC)
Table S3 Sequence identity between PGBD3 and pseudogenes.
Found at: doi:10.1371/journal.pgen.1000031.s003 (0.04 MB
DOC)
Table S4 Locations of human MER85 elements and MER85-
associated genes.
Found at: doi:10.1371/journal.pgen.1000031.s004 (0.09 MB XLS)
Table S5 L2L results comparing MER85-associated genes to the
L2L microarray database, with P values corrected by random-data
simulation.
Found at: doi:10.1371/journal.pgen.1000031.s005 (0.17 MB XLS)
Table S6 L2L microarray database results analyzed by groups of
similar database lists.
Found at: doi:10.1371/journal.pgen.1000031.s006 (0.02 MB XLS)
Table S7 L2L results comparing MER85-associated genes to
Gene Ontology Molecular Function terms, with P values corrected
by random-data simulation.
Found at: doi:10.1371/journal.pgen.1000031.s007 (0.17 MB XLS)
Figure S1 Quantitation of the relative abundance of CSB and
CSB-PGBD3 fusion transcripts in HeLa cDNA. (A) Ratio of
abundance between similarly sized CSB and fusion PCR products,
assayed by real time RT-PCR. The average ratio of all eighteen
fusion:CSB comparisons is 2.0:1. (B) Expected sizes of all PCR
products.
Found at: doi:10.1371/journal.pgen.1000031.s008 (1.07 MB
DOC)
Figure S2 Fusion mRNA is more abundant than CSB in other
cell lines. Three pairs of primer combinations (A1–D1, A2–D2
and B1–E1) were tested on cDNA from CSB-null, CSB-wt and
WI38/hTERT cell lines. In all cases, the fusion PCR products
were substantially more abundant than the corresponding CSB
products as quantified by real time RT-PCR.
Found at: doi:10.1371/journal.pgen.1000031.s009 (0.65 MB TIF)
Figure S3 Additional Western blots for CSB and the fusion
protein. (A) Western blot using a Cterminal antibody against CSB
reveals only the expected major band for full length CSB(filled
arrowhead) in MRC5 (SV40-immortalized human fetal lung
fibroblast), E61ANd(GM00739B fibroblasts from compound
heterozygote CS1AN, immortalized by SV40 and rescued by wt
CSB cDNA [1]), Saos-2 (human osteosarcoma) and HT1080
(human fibrosarcoma); full length CSB is not seen in CS1AN/SV
(the SV40-immortalized but unrescued parent of E61ANd). The
.250 kDa species (labeled X) is seen only with Cterminal
antibody and correlates with the abundance of full length CSB,
but is also weakly expressed in the CS1AN/SV line lacking full
length CSB; X may be a modified form of full length CSB, and
weak expression in CS1AN/SV may indicate that one or both of
the nonsense mutations in this compound heterozygote are leaky
[2]. (B) Western blot using an N-terminal antibody against CSB
reveals both full length CSB (filled arrowhead) and a second major
band corresponding to the fusion protein (hollow arrowhead) in
MRC5, Saos-2, and HT1080. We were also able to detect the
fusion protein, but not full-length CSB, in SV40-immortalized
primary fibroblasts from CSB patient CS1BE (derived from
GM01629; data not shown). In agreement with our data, a band
corresponding to the CSB-PGBD3 fusion protein was previously
seen in the normal SV40-transformed WI38VA13 line [3] and in
normal hTERT-immortalized BJ1 fibroblasts [4]. Although
present in our CS1AN/hTERT line (Fig. 3), the fusion protein
appears to be absent in the CS1AN/SV line (see also [3,4]) and its
derivatives, suggesting that SV40 immortalization may suppress
the fusion protein. (C) Western blots using an N-terminal CSB
antibody reveal only the fusion protein (hollow arrowhead) and
not fulllength CSB (filled arrowhead) in three different primary
CSB cells. GM00739B is derived from patient CS1AN and is the
parent of our hTERT-immortalized derivatives (CSB-wt and
CSB-null lines), thus demonstrating that the fusion protein is not
an artifact of immortalization. GM10903 and GM10905 are from
two patients diagnosed with the DeSanctis-Cacchione variant of
XP (XP/DCS; XP61SF and XP63SF in Table S3). The same
homozygous R735STOP mutation shared by both patients is also
associated with classical CS in another patient (CS1TAN) and the
clinical overlap between CSB-XP/DCS and CSB-CS is substan-
tial, including photosensitivity (but not skin cancers), mental
retardation and severe growth failure [5]. The fusion protein
might therefore contribute to the entire spectrum of CSB-
associated disease. Markers are in kDa. The apparent sizes of
full-length CSB and the fusion protein in these panels and in
Figures 3 and 4 are similar but not identical because the gels were
run under various conditions and using different markers. Figures 3
and 4 should be considered the size standard; these supporting
panels assess the relative abundance of CSB and the fusion protein
in different cells and cell lines. 1. Troelstra C, van Gool A, de Wit
J, Vermeulen W, Bootsma D, et al. (1992) ERCC6, a member of a
subfamily of putative helicases, is involved in Cockayne’s
syndrome and preferential repair of active genes. Cell 71: 939–
953. 2. Keeling KM, Lanier J, Du M, Salas-Marco J, Gao L, et al.
(2004) Leaky termination at premature stop codons antagonizes
nonsense-mediated mRNA decay in S. cerevisiae. Rna 10: 691–
703. 3. Horibata K, Iwamoto Y, Kuraoka I, Jaspers NG,
Kurimasa A, et al. (2004) Complete absence of Cockayne
syndrome group B gene product gives rise to UV-sensitive
syndrome but not Cockayne syndrome. Proc Natl Acad Sci U S
A 101: 15410–15415. 4. Groisman R, Kuraoka I, Chevallier O,
Gaye N, Magnaldo T, et al. (2006) CSAdependent degradation of
CSB by the ubiquitin-proteasome pathway establishes a link
between complementation factors of the Cockayne syndrome.
Genes Dev 20: 1429–1434. 5. Greenhaw GA, Hebert A, Duke-
Woodside ME, Butler IJ, Hecht JT, et al. (1992)Xeroderma
pigmentosum and Cockayne syndrome: overlapping clinical and
biochemical phenotypes. Am J Hum Genet 50: 677–689.
Found at: doi:10.1371/journal.pgen.1000031.s010 (4.58 MB TIF)
Figure S4 Conservation of the 39 splice site in PGBD3. (A)
Conserved 39 splice site in the genomic sequence of PGBD3 and
pseudogenes for human (Hs, Homo sapiens), chimpanzee (Pt, Pan
troglodytes), Rhesus (Mm, Macaca mulatta), marmoset (Ct,
Callithrix jacchus) and orangutan (Pa, Pongo abelli), organized
by gene. Uppercase letters represent exon sequence; ATG at the
59 end is the start codon of the PiggyBac ORF. Notably, the entire
sequence shown is perfectly conserved in PGBD3 from all three
CSB-PiggyBac Fusion Protein in CS
PLoS Genetics | www.plosgenetics.org 12 2008 | Volume 4 | Issue 3 | e1000031species. (B) As for (A), organized by species to show the variations
between PGBD3 and its pseudogenes.
Found at: doi:10.1371/journal.pgen.1000031.s011 (1.47 MB TIF)
Figure S5 Conservation of the polyadenylation signal in
PGBD3. (A) Conserved polyadenylation signals in the genomic
sequence of PGBD3 and pseudogenes for human (Hs), chimpan-
zee (Pt), Rhesus (Mm), marmoset (Ct) and orangutan (Pa),
organized by gene. Uppercase letters represent the AAUAAA
motif. Dashes indicate pseudogenes for which the 39 end (including
the polyadenylation site) is no longer present. (B) As for (A),
organized by species to show the variations between PGBD3 and
its pseudogenes.
Found at: doi:10.1371/journal.pgen.1000031.s012 (1.17 MB TIF)
Figure S6 Schematic of PGBD3 element and the relationship
with PGBD3 pseudogenes. The 59 and 39 ends of PGBD3
correspond to the 59 arm (100 nt) and 39 arm (40 nt) of a MER85
element (140 nt). The 13 nt inverted repeats of MER85 define the
boundaries of the element, which is flanked by a TTAA target site
duplication. Only two pseudogenes span the entire element, but all
pseudogenes with intact ends share the same flanking features as
PGBD3, and exhibit no homology to PGBD3 beyond the TTAA
duplications. The 39 end of PGBD3P3 is inverted, but the inverted
sequence is as similar to PGBD3 as the remainder. An AluSx
SINE has inserted into PGBD3P4 between the MER85 element
and the 39 SS. Also note two fragments (yellow) that appear to be
derivatives of the left end of MER85, spanning 14 and 25 nt. The
fragments each include the 5 innermost nt of the MER85 inverted
repeat, but also share 8 further nt of unique flanking inverted
repeat. Chimpanzee and Rhesus PGBD3 are structurally identical
to human PGBD3, including all of the elements displayed. The
chimpanzee pseudogenes are essentially identical to their human
homologs. The Rhesus pseudogenes are more highly degraded,
particularly at the 39 end.
Found at: doi:10.1371/journal.pgen.1000031.s013 (0.61 MB TIF)
Figure S7 The putative catalytic motif is DDD in all
pseudogenes, but DND in all PGBD3s. PiggyBac transposases
share a DDD motif [1] that may be analogous to the
metalcoordinating DDE motif common to other transposase
families [2]. The most likely candidates for this motif in human
PGBD3 are D270, N352 and D467. N352 is the result of a G to A
mutation that occurred after generation of the four pseudogenes;
all pseudogenes encode D at this position. (A) Genomic sequence
of the three putative catalytic residues of PGBD3 and pseudogenes
for human (Hs), chimpanzee (Pt), Rhesus (Mm), marmoset (Ct)
and orangutan (Pa) organized by gene. Uppercase letters are the
codons for the three residues. Dashes indicate pseudogenes for
which the homologous sequence is no longer present; in addition,
a 49 nt gap in the genome sequence of orangutan obscures D270.
(B) As for (A), organized by species to show the variations between
PGBD3 and its pseudogenes.
Found at: doi:10.1371/journal.pgen.1000031.s014 (1.30 MB TIF)
Figure S8 Consensus sequence of putative catalytic motif is
DDD in galago PGBD3-related sequences. Six of seven sequences
encode D at position 270, and six of seven encode D at 467. At
position 352, four encode D while three encode K, G or N.
Numbers designtating the PGBD3-like sequences represent the
galago (Otolemur garnetti, Og) genomic contig on which the
sequence is located.
Found at: doi:10.1371/journal.pgen.1000031.s015 (0.36 MB TIF)
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